Pella Regional, Knoxville Hospital break ground on cancer treatment facility
PELLA — Pella Regional Medical Center and Knoxville Hospital and Clinics broke ground on a project to bring improved cancer treatment to Marion County.
Members of the hospitals and community celebrated the beginning of construction on the new South Central Iowa Radiation Center at the Pella Regional campus Thursday. According to Pella Regional CEO Bob Kroese, the project came as a collaboration built on a mutual need for patients in both communities, and in Marion County as a whole.
"It's kind of a first of its kind," Kroese said. "But when we both realized — both of our organizations realized — there was something we wanted to do desperately for our communities is to bring the radiation therapy to our community, and we both found out we were interested in doing it, we decided to talk it over with each other and decided … maybe if we do one united front, it will serve that large patient population even more effectively and really reduce the travel times for people that need that care."
The 7,800-square-foot facility is budgeted at $14 million, and is expected to include diagnostic tools and treatment technologies like a TrueBeam linear accelerator to deliver radiation treatments and a combined Biograph Trinion PET/CT unit for diagnosing cancer and determining course of treatment.
Iowa has the second highest cancer rates in the United States and a according to Kroese, the new center will play a major role in fighting the issue locally.
"It's very, very unfortunate that our cancer incidences are as high as they are, but it's up to us professionally through our missions to be able to provide very, very, high quality … of care, but also do whatever we can to reduce the burden of travel," Kroese said. "If we do that, we're fulfilling our mission and providing a great service for this area."
Knoxville Hospital and Clinics CEO Kevin Kincaid reflected this when speaking at the groundbreaking, stressing the importance of nearby care and reduced travel.
"And we all know that when you're able to deliver care — especially around cancer — locally, what we're giving people back is the biggest gift at all when you're talking about cancer, and that's time," he said. "So that's what we're interested in, and that's what we're going to do."
The new radiation and oncology center is expected to be opened in 2027.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
09-05-2025
- Yahoo
Pella Regional, Knoxville Hospital break ground on cancer treatment facility
PELLA — Pella Regional Medical Center and Knoxville Hospital and Clinics broke ground on a project to bring improved cancer treatment to Marion County. Members of the hospitals and community celebrated the beginning of construction on the new South Central Iowa Radiation Center at the Pella Regional campus Thursday. According to Pella Regional CEO Bob Kroese, the project came as a collaboration built on a mutual need for patients in both communities, and in Marion County as a whole. "It's kind of a first of its kind," Kroese said. "But when we both realized — both of our organizations realized — there was something we wanted to do desperately for our communities is to bring the radiation therapy to our community, and we both found out we were interested in doing it, we decided to talk it over with each other and decided … maybe if we do one united front, it will serve that large patient population even more effectively and really reduce the travel times for people that need that care." The 7,800-square-foot facility is budgeted at $14 million, and is expected to include diagnostic tools and treatment technologies like a TrueBeam linear accelerator to deliver radiation treatments and a combined Biograph Trinion PET/CT unit for diagnosing cancer and determining course of treatment. Iowa has the second highest cancer rates in the United States and a according to Kroese, the new center will play a major role in fighting the issue locally. "It's very, very unfortunate that our cancer incidences are as high as they are, but it's up to us professionally through our missions to be able to provide very, very, high quality … of care, but also do whatever we can to reduce the burden of travel," Kroese said. "If we do that, we're fulfilling our mission and providing a great service for this area." Knoxville Hospital and Clinics CEO Kevin Kincaid reflected this when speaking at the groundbreaking, stressing the importance of nearby care and reduced travel. "And we all know that when you're able to deliver care — especially around cancer — locally, what we're giving people back is the biggest gift at all when you're talking about cancer, and that's time," he said. "So that's what we're interested in, and that's what we're going to do." The new radiation and oncology center is expected to be opened in 2027.
Yahoo
01-05-2025
- Yahoo
More Impact, Together: Varian and Siemens Healthineers Portfolios Highlight More Impact, Innovations and More Breakthroughs Throughout Cancer Care Journey at ESTRO 2025
PALO ALTO, Calif., May 01, 2025--(BUSINESS WIRE)--Varian, a Siemens Healthineers company, will showcase an integrated portfolio designed to streamline workflows, and aiming to enhance patient experience and improve patient outcomes from screening to survivorship at the 2025 European Society for Radiotherapy and Oncology (ESTRO) annual meeting, May 2-6, in Vienna, Austria. "As part of Siemens Healthineers, we are uniquely positioned to transform cancer and beyond, and we are supercharging our commitment to patient-centricity with greater scale and impact," said Arthur Kaindl, Head of Varian. "Our accelerated pace of innovation demonstrates that we offer more impact, together, in our mission toward a world without fear of cancer." Varian and Siemens Healthineers will announce ground-breaking technologies empowering access to MRI for radiotherapy practices with the goal of establishing MRI in daily clinical routine, as well as showcase how its RapidArc Dynamic solution enables greater efficiency, precision, and flexibility in treatment planning and delivery at its booth (ESTRO #250), Friday, May 2, at 19:04 CEST. Varian's RapidArc Dynamic solution, available as an optional feature for the latest versions of Eclipse treatment planning software and the TrueBeam radiotherapy delivery platform, is powered by next-generation algorithms, combining a dynamic collimator and modulated ports working seamlessly in a single arc treatment field to provide clinicians with supreme control for optimal dose delivery. More innovations, together With the latest version of the ARIA CORE oncology management solution, Varian has strengthened integration with its software solutions, Noona and ARIA CORE Insights, to provide a seamless user experience and help streamline clinical workflows. Varian will also introduce ARIA CORE Automations, enabling users to automate workflows within ARIA CORE to drive efficiency and establish standardization. As an example of Varian and Siemens Healthineers' expanded strength as one team, Siemens Healthineers will be introducing Oncology Exchange, which improves integration by automatically transferring ARIA CORE prescription information to setup and configure the CT simulator. Reflecting the growing use of MRI in radiation therapy, Siemens Healthineers will present dedicated deep-learning algorithms for MRI autocontouring of brain metastases, and autocontouring of brain organs at risk – optimized for use with HyperArc high-definition radiotherapy. More breakthroughs, together With almost 40 Varian-supported abstracts accepted as part of ESTRO 2025, Varian is proud to collaborate with research leaders in the field. Included in this year's ESTRO program is evidence generated by Varian-sponsored clinical trials and consortium members underscoring the value of Varian's HyperSight imaging, an optional feature for selected Varian linacs, and Varian's Ethos adaptive radiotherapy system. "We recognize that every step of the cancer care journey needs to be effective and efficient, and delivered at the highest possible levels of clinical confidence and patient experience," Kaindl said. "We are committed to driving sustainable innovations that introduce new and enhanced tools in the fight against cancer." © 2025 VARIAN MEDICAL SYSTEMS, INC. All trademarks are the property of their respective owners. QR700022422 About Varian At Varian, a Siemens Healthineers company, we envision a world without fear of cancer. For more than 75 years, Varian has developed, built, and delivered innovative technologies and solutions that help care providers around the globe treat millions of patients each year. Today, as a Siemens Healthineers company, we support every step of the cancer care journey – from screening to survivorship. From advanced imaging and radiation therapy to comprehensive software and services, to interventional radiology, we are harnessing the power of our perspective while also pursuing clinical research to create a more efficient, and more personalized care pathway. Because, for cancer patients everywhere, their fight is our fight. For more information, visit View source version on Contacts Varian Press ContactKristin CoreyVarian Corporate Sign in to access your portfolio
Business Wire
01-05-2025
- Business Wire
More Impact, Together: Varian and Siemens Healthineers Portfolios Highlight More Impact, Innovations and More Breakthroughs Throughout Cancer Care Journey at ESTRO 2025
PALO ALTO, Calif.--(BUSINESS WIRE)--Varian, a Siemens Healthineers company, will showcase an integrated portfolio designed to streamline workflows, and aiming to enhance patient experience and improve patient outcomes from screening to survivorship at the 2025 European Society for Radiotherapy and Oncology (ESTRO) annual meeting, May 2-6, in Vienna, Austria. 'Our accelerated pace of innovation demonstrates that we offer more impact, together, in our mission toward a world without fear of cancer.' Share 'As part of Siemens Healthineers, we are uniquely positioned to transform cancer and beyond, and we are supercharging our commitment to patient-centricity with greater scale and impact,' said Arthur Kaindl, Head of Varian. 'Our accelerated pace of innovation demonstrates that we offer more impact, together, in our mission toward a world without fear of cancer.' Varian and Siemens Healthineers will announce ground-breaking technologies empowering access to MRI for radiotherapy practices with the goal of establishing MRI in daily clinical routine, as well as showcase how its RapidArc Dynamic solution enables greater efficiency, precision, and flexibility in treatment planning and delivery at its booth (ESTRO #250), Friday, May 2, at 19:04 CEST. Varian's RapidArc Dynamic solution, available as an optional feature for the latest versions of Eclipse treatment planning software and the TrueBeam radiotherapy delivery platform, is powered by next-generation algorithms, combining a dynamic collimator and modulated ports working seamlessly in a single arc treatment field to provide clinicians with supreme control for optimal dose delivery. More innovations, together With the latest version of the ARIA CORE oncology management solution, Varian has strengthened integration with its software solutions, Noona and ARIA CORE Insights, to provide a seamless user experience and help streamline clinical workflows. Varian will also introduce ARIA CORE Automations, enabling users to automate workflows within ARIA CORE to drive efficiency and establish standardization. As an example of Varian and Siemens Healthineers' expanded strength as one team, Siemens Healthineers will be introducing Oncology Exchange, which improves integration by automatically transferring ARIA CORE prescription information to setup and configure the CT simulator. Reflecting the growing use of MRI in radiation therapy, Siemens Healthineers will present dedicated deep-learning algorithms for MRI autocontouring of brain metastases, and autocontouring of brain organs at risk – optimized for use with HyperArc high-definition radiotherapy. More breakthroughs, together With almost 40 Varian-supported abstracts accepted as part of ESTRO 2025, Varian is proud to collaborate with research leaders in the field. Included in this year's ESTRO program is evidence generated by Varian-sponsored clinical trials and consortium members underscoring the value of Varian's HyperSight imaging, an optional feature for selected Varian linacs, and Varian's Ethos adaptive radiotherapy system. 'We recognize that every step of the cancer care journey needs to be effective and efficient, and delivered at the highest possible levels of clinical confidence and patient experience,' Kaindl said. 'We are committed to driving sustainable innovations that introduce new and enhanced tools in the fight against cancer.' © 2025 VARIAN MEDICAL SYSTEMS, INC. All trademarks are the property of their respective owners. QR700022422 About Varian At Varian, a Siemens Healthineers company, we envision a world without fear of cancer. For more than 75 years, Varian has developed, built, and delivered innovative technologies and solutions that help care providers around the globe treat millions of patients each year. Today, as a Siemens Healthineers company, we support every step of the cancer care journey – from screening to survivorship. From advanced imaging and radiation therapy to comprehensive software and services, to interventional radiology, we are harnessing the power of our perspective while also pursuing clinical research to create a more efficient, and more personalized care pathway. Because, for cancer patients everywhere, their fight is our fight. For more information, visit
